Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial

Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial

By Gilmar Reis, et al. PREPRINT August 23, 2021 ABSTRACT Background Recent evidence indicates a potential therapeutic role of fluvoxamine for COVID-19. In the TOGETHER randomized platform clinical trial for acutely symptomatic patients with COVID-19, we assessed...

read more
RAPID Clinical Trial Led by Unity Health Toronto Demonstrates Heparin May Help Moderately Ill & Hospitalized COVID-19 Patients

RAPID Clinical Trial Led by Unity Health Toronto Demonstrates Heparin May Help Moderately Ill & Hospitalized COVID-19 Patients

A multinational, multi-site team of researchers led by Peter Jüni of St. Michael’s Hospital and the University of Toronto in Canada investigated the efficacy of heparin as a treatment for moderate to severe SARS-CoV-2 infection, the virus behind the COVID-19 pandemic....

read more
Japanese-Led Team’s Preclinical Research Indicate Huge Potential for the Repurposed Drug Combo of Cepharanthine/Nelfinavir to Destroy COVID-19

Japanese-Led Team’s Preclinical Research Indicate Huge Potential for the Repurposed Drug Combo of Cepharanthine/Nelfinavir to Destroy COVID-19

June 13, 2021 ~ TrialSite News Japanese-Led Team’s Preclinical Research Indicate Huge Potential for the Repurposed Drug Combo of Cepharanthine/Nelfinavir to Destroy COVID-19 A team of researchers from Japan, America, and the United Kingdom recently launched a study to...

read more